Obinutuzumab in Adult Rituximab-Dependent Nephrotic Syndrome

NCT07233330 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Nephrotic Syndrome，Idiopathic

Interventions

DRUG: Obinutuzumab

Sponsor

Mario Negri Institute for Pharmacological Research